Ohio Court Allows Cities to Enforce Ban on Flavored Tobacco

Regulations by 2FIRSTS.ai
May.20.2024
Ohio Court Allows Cities to Enforce Ban on Flavored Tobacco
Ohio Judge Rules Statewide Flavor Ban Unconstitutional, Allowing 21 Cities to Enforce Ban on Sale of Flavored Tobacco Products.

According to a report from Halfwheel on May 17th, there has been an update after 18 months regarding the ban on flavored tobacco products in Ohio. Judge Mark Serrott ruled that the recently passed statewide preemption law is unconstitutional, allowing for the enforcement of bans on the sale of flavored tobacco products in 21 cities involved in the lawsuit.

 

The controversy began in December 2022, when the city council of Columbus, Ohio, as the main plaintiff in the lawsuit, passed a ban on the sale of flavored tobacco products. In response, the Republican-controlled Ohio Legislature, during a special session focused on other issues, quickly passed a preemptive measure aimed at preventing cities from implementing stricter bans than state law.

 

In January 2023, Governor Mike DeWine, a Republican, vetoed a bill that would have banned the sale of flavored e-cigarettes, citing his longstanding opposition to the measure. Due to technical issues, the state legislature was unable to override DeWine's veto.

 

Last year, the state legislature attempted to pass a preemptive clause once again and successfully overturned Governor DeWine's second veto. Subsequently, cities like Columbus began to sue, Judge Serothe issued a temporary injunction allowing Columbus's law to remain in effect and halting the implementation of the state law.

 

However, this issue remains unresolved. The state government has stated that it will appeal the ruling by Judge Serott to the Tenth Circuit Court. Cities not involved in this lawsuit are still bound by state law.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
During the FDA PMTA roundtable session on “Studies of Adult Benefit,” officials said flavored ENDS must demonstrate “added benefit” over tobacco-flavored products under the APPH standard, including sustained complete switching evidence. Small manufacturers questioned switching benchmarks, study duration, and bridging expectations.
Feb.11
Alabama SB9 would treat vaping like smoking under indoor public-space restrictions
Alabama SB9 would treat vaping like smoking under indoor public-space restrictions
Alabama’s Senate Bill 9 would modernize the state’s indoor air quality laws by treating electronic nicotine delivery systems, including e-cigarettes and vape pens, the same as traditional tobacco smoking in indoor public spaces. Sponsored by Sen.
Jan.05 by 2FIRSTS.ai
22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap
22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap
22nd Century Group (Nasdaq: XXII) reported early commercial momentum for its FDA-authorized VLN® very low nicotine cigarettes, distributing approximately 8,800 cartons across 1,700 new U.S. retail outlets in the fourth quarter of 2025, while forecasting expansion to more than 5,000 retail points in 2026.
Business
Feb.24
Police dismantle a network of 50+ stores selling unmarked nicotine products in the Moscow region
Police dismantle a network of 50+ stores selling unmarked nicotine products in the Moscow region
TASS reported that police dismantled a distribution network in the Moscow region selling nicotine-containing products, e-cigarettes and vapes without mandatory markings, with organizers earning more than 10 million rubles per month (more than about $130,000). Interior Ministry spokesperson Irina Volk said some items were labeled with counterfeit identification tools of the Chestny Znak system, while others had no codes.
Dec.30 by 2FIRSTS.ai
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA officials said manufacturing consistency is a core prerequisite for ENDS PMTA reviews, not a procedural formality. During its February 10, 2026 roundtable, the agency outlined expectations for quality management systems, manufacturing documentation, nicotine control, stability studies, and risk mitigation, emphasizing that robust manufacturing evidence underpins determinations of whether products are appropriate for the protection of public health.
Feb.11
South Korea’s appeal court again sides with KT&G, Philip Morris Korea and BAT Korea in $36.24 million case
South Korea’s appeal court again sides with KT&G, Philip Morris Korea and BAT Korea in $36.24 million case
South Korea’s National Health Insurance Service (NHIS) has again lost on appeal in its damages lawsuit against KT&G, Philip Morris Korea and BAT Korea, seeking ₩53.3 billion (about $36.244 million).
Jan.15 by 2FIRSTS.ai